CKPT - Checkpoint Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

CKPT is currently covered by 4 analysts with an average price target of $42.25. This is a potential upside of $40.8 (2813.79%) from yesterday's end of day stock price of $1.45.

Checkpoint Therapeutics's activity chart (see below) currently has 6 price targets and 27 ratings on display. The stock rating distribution of CKPT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 62.33 days.

Highest price target for CKPT is $8, Lowest price target is $8, average price target is $42.25.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 19-Dec-2023. First documented stock forecast 08-Dec-2017.

Best performing analysts who are covering CKPT - Checkpoint Therapeutics:

Thomas Flaten Joseph Pantginis Jennifer Kim

Currently out of the existing stock ratings of CKPT, 20 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$6.55 (451.72%)

8

4 months 5 days ago

1/3 (33.33%)

$6.17 (337.16%)

187

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CKPT (Checkpoint Therapeutics) average time for price targets to be met?

On average it took 62.33 days on average for the stock forecasts to be realized with a an average price target met ratio 11.11

Which analyst has the current highest performing score on CKPT (Checkpoint Therapeutics) with a proven track record?

THOMAS FLATEN

Which analyst has the current lower performing score on CKPT (Checkpoint Therapeutics) with a proven track record?

JENNIFER KIM

Which analyst has the most public recommendations on CKPT (Checkpoint Therapeutics)?

Thomas Flaten works at LAKE STREET and has 1 price targets and 2 ratings on CKPT

Which analyst is the currently most bullish on CKPT (Checkpoint Therapeutics)?

Thomas Flaten with highest potential upside - $6.55

Which analyst is the currently most reserved on CKPT (Checkpoint Therapeutics)?

Joseph Pantginis with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?